Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBCWW) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $11.6 million.

  • SBC Medical Group Holdings' Cash from Financing Activities fell 106.98% to $11.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.9 million, marking a year-over-year increase of 16055.55%. This contributed to the annual value of $23.0 million for FY2024, which is 27431.17% up from last year.
  • As of Q3 2025, SBC Medical Group Holdings' Cash from Financing Activities stood at $11.6 million, which was down 106.98% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, SBC Medical Group Holdings' Cash from Financing Activities ranged from a high of $105.3 million in Q3 2023 and a low of -$280380.0 during Q1 2025
  • Moreover, its 3-year median value for Cash from Financing Activities was $7.2 million (2025), whereas its average is $16.3 million.
  • The largest annual percentage gain for SBC Medical Group Holdings' Cash from Financing Activities in the last 5 years was 1049167.03% (2025), contrasted with its biggest fall of 59699.46% (2025).
  • SBC Medical Group Holdings' Cash from Financing Activities (Quarter) stood at -$127221.0 in 2023, then surged by 9046.13% to $11.4 million in 2024, then increased by 1.64% to $11.6 million in 2025.
  • Its last three reported values are $11.6 million in Q3 2025, $7.2 million for Q2 2025, and -$280380.0 during Q1 2025.